“The Molson” is a low-barrier, peer-staffed, supervised consumption site located in Vancouver,
Canada. In addition to overdose response, this site offers drug checking and a colocated …

Best evidence from cohort and modeling studies suggests that SISs are associated with
lower overdose mortality (88 fewer overdose deaths per 100 000 person-years [PYs]), 67% …

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing
during the pandemic documented through an environmental scan of addiction and harm …

… Christy Sutherland and Thomas Kerr contributed to study design and manuscript editing.
Ryan McNeil oversaw study design and implementation, contributed to data collection and …

This clinical guideline provides 3 key recommendations focused on defining the patient
population that should be considered for injectable opioid agonist treatment and outlining …

Background Illicit drug injecting is a well-established risk factor for morbidity and mortality.
However, a limited number of prospective studies have examined the independent effect of …

… Competing interests: Sukhpreet Klaire is a physician and Christy Sutherland is the medical
… Christy Sutherland also reports grants from Health Canada and consulting fees from AIDS …

North America is experiencing an overdose crisis driven by fentanyl, related analogues, and
fentanyl-adulterated drugs. In response, there have been increased calls for “safe supply” …

Introduction and Aims Buprenorphine/naloxone is an evidence‐based treatment for opioid
use disorder, but an identified limitation is the period of required opioid abstinence prior to …

Background: Injectable opioid agonist treatment (iOAT) is an emerging evidence-based
option in the continuum of care for opioid use disorder in parts of Canada. Our study objective …